Secondary Cancer Risk Among Patients With Primary Cutaneous B-cell Lymphoma.
作者信息
Shah Vrusha K, Behbahani Sara, Barnes Jeffrey, Perlman Katherine, Chen Steven T
机构信息
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston.
出版信息
JAMA Dermatol. 2025 Apr 30. doi: 10.1001/jamadermatol.2025.0924.
Abstract
摘要
相似文献
1
Secondary Cancer Risk Among Patients With Primary Cutaneous B-cell Lymphoma.
JAMA Dermatol. 2025 Apr 30. doi: 10.1001/jamadermatol.2025.0924.
2
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study.
Transplant Cell Ther. 2025 Jun 18. doi: 10.1016/j.jtct.2025.06.004.
3
Rare Case of Primary Bone Lymphoma.
Cureus. 2025 May 19;17(5):e84415. doi: 10.7759/cureus.84415. eCollection 2025 May.
4
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD013365. doi: 10.1002/14651858.CD013365.pub2.
5
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
6
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial.
JAMA Oncol. 2024 Sep 1;10(9):1195-1203. doi: 10.1001/jamaoncol.2024.2112.
7
Influenza vaccines in immunosuppressed adults with cancer.
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD008983. doi: 10.1002/14651858.CD008983.pub3.
8
Indoor tanning and the risk of developing non-cutaneous cancers: a systematic review and meta-analysis.
Cancer Causes Control. 2018 Oct;29(10):937-950. doi: 10.1007/s10552-018-1070-8. Epub 2018 Aug 11.
9
Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
Cancer Control. 2012 Jul;19(3):236-44. doi: 10.1177/107327481201900308.
10
Antioxidants for female subfertility.
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3.
本文引用的文献
1
Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
J Insur Med. 2023 Jul 1;50(1):1-35. doi: 10.17849/insm-50-1-1-35.1.
2
Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry.
Front Med (Lausanne). 2023 Apr 6;10:1110511. doi: 10.3389/fmed.2023.1110511. eCollection 2023.
3
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study.
Acta Derm Venereol. 2022 Apr 4;102:adv00687. doi: 10.2340/actadv.v102.319.
4
Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
J Am Acad Dermatol. 2020 Aug;83(2):404-411. doi: 10.1016/j.jaad.2019.07.075. Epub 2019 Jul 30.
5
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.
Blood. 2019 Apr 18;133(16):1703-1714. doi: 10.1182/blood-2018-11-881268. Epub 2019 Jan 11.
6
Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
An Bras Dermatol. 2015 Sep-Oct;90(5):687-706. doi: 10.1590/abd1806-4841.20153638.
Zotero 插件